Physician profile
Daniel Rae York
NPI 1326359704
$14,796.40
in general payments reported to CMS, 2019-2025
24 companies · $666 in 2025
The $666 reported for 2025 was more than what 86% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $538 · 2021: $5,580 · 2022: $3,812 · 2023: $3,274 · 2024: $419 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,750 · Food and Beverage: $1,150 · Travel and Lodging: $359 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,750.00 |
| Food and Beverage | $1,150.13 |
| Travel and Lodging | $359.06 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $9,651.98 | 2021-2025 | Nexplanon |
| Cgg Medical INC | $2,428.07 | 2022-2023 | |
| Intuitive Surgical, INC. | $614.53 | 2020-2025 | |
| Coloplast Corp | $325.96 | 2019-2020 | |
| Arthrex, INC. | $312.08 | 2022-2023 | |
| Astellas Pharma US INC | $242.24 | 2019-2025 | Veozah |
| Daiichi Sankyo INC. | $175.85 | 2020-2025 | Injectafer |
| Duchesnay USA Incorporated | $139.90 | 2019 | |
| Hologic Sales and Service, LLC | $139.56 | 2023-2025 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Shield Therapeutics INC | $138.48 | 2024-2025 | |
| Abbvie INC. | $106.95 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.31 | 2020-2025 | |
| Amgen INC. | $74.11 | 2019-2020 | |
| Pfizer INC. | $64.47 | 2021-2024 | |
| Optumhealth Care Solutions, LLC | $43.98 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $41.76 | 2024-2025 | |
| Solventum Corporation | $38.82 | 2024-2025 | Prevena |
| Merck Sharp & Dohme LLC | $31.80 | 2019-2020 | |
| Olympus America INC. | $29.39 | 2022 | |
| Novo Nordisk INC | $25.81 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $23.40 | 2025 | Inspire |
| Pharmacosmos Therapeutics INC. | $20.16 | 2022 | |
| Sumitomo Pharma America, INC. | $14.73 | 2024 | Myfembree |
| Amag Pharmaceuticals, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel York listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.